
James W. Rocco MD PhD
Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery
Chairman Department of Otolaryngology. Professor and Mary and John Alford Chair in Head and Neck Research. The Ohio State University and Wexner Medical Center and James Cancer Hospital
Join to View Full Profile
915 Olentangy River RdColumbus, OH 43212
Phone+1 614-366-3687
Fax+1 614-293-7292
Dr. Rocco is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I’m an otolaryngologist serving as chairman of the Department of Otolaryngology – Head and Neck Surgery at The Ohio State Wexner Medical Center. I also serve as director of the Head and Neck Disease Specific Research Group at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. I previously served as
director of the Head and Neck Oncologic Surgery Division and the Head and Neck Service Line at the OSUCCC – James.
As a member of the Translational Therapeutics Program at the OSUCCC – James, my research focuses on the origins of intra-tumor heterogeneity during tumor development, novel biomarkers for head and neck cancer, molecular mechanisms that these biomarkers represent and how these biomarkers might inform decisions about therapy. I'm also actively involved in clinical trials at The
James and help direct nationwide efforts through my service on the NRG Oncology and ECOG-ACRIN head and neck committees, and as co-chair of the NCI Head and Neck Task Force on Metastatic and Recurrent Disease.
I have co-authored many articles in well-known publications, including Cancer Cell, Cell, PLoS Medicine, Journal of Clinical Oncology, Journal of Clinical Investigation, Cancer Research, Clinical Cancer Research, Genome Research and Cancer.
Education & Training
Johns Hopkins UniversityResidency, Otolaryngology - Head and Neck Surgery, 1995 - 1999
Johns Hopkins UniversityInternship, Surgery, 1994 - 1995
Icahn School of Medicine at Mount SinaiClass of 1994
Mount SinaiPh.D, Physiology Biophysics, Basic Science Achievement, 1986 - 1993
Certifications & Licensure
OH State Medical License 2014 - 2028
MA State Medical License 1999 - 2018
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
Clinical Trials
- Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer Start of enrollment: 2007 Feb 01
- Collection of Tissue Samples for Cancer Research Start of enrollment: 2006 Jul 06
- Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Start of enrollment: 2017 Dec 20
Publications & Presentations
PubMed
- Associations Between Preexisting Depression and Anxiety and Postoperative Outcomes Among Medicare Beneficiaries Undergoing Head and Neck Cancer Surgery.Xiaodan Hu, Daniel Gilmore, Ericka L Erickson, Catherine T Haring, Kyle VanKoevering
Head & Neck. 2026-05-04 - Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer.Jack L Birkenbeuel, Christopher Noel, Sujith Baliga, Emile Gogineni, Dukagjin M Blakaj
JAMA Otolaryngology-- Head & Neck Surgery. 2026-05-01 - Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab...Robin Park, Fahad Rind, Tyler Kristoff, Jiannong Li, Michael Schell
American Journal of Clinical Oncology. 2026-04-01
Journal Articles
- Predictors of Gastrostomy Tube Dependence in Surgically Managed Oropharyngeal Squamous Cell CarcinomaStephen Y Kang, James W Rocco, Michael J Cipolla, Amit Agrawal, David E Schuller, Peter T Dziegielewski, Ricardo L Carrau, Matthew O Old, Enver Ozer, Vivek R Varma, Th..., The Laryngoscope
Press Mentions
Medical Schools Send Early Graduates to Fight CoronavirusApril 13th, 2020
Ohio State University College of Medicine Offers Pandemic and Disaster Medicine ElectiveApril 9th, 2020
Board of Trustees to Vote on Early Graduation for Senior Medical StudentsApril 9th, 2020
Professional Memberships
- Member
- Member
- Member
- Member
- American Head and Neck SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









